Article info

Download PDFPDF

IBD BioResource: an open-access platform of 25 000 patients to accelerate research in Crohn’s and Colitis
  1. Correspondence to Dr Miles Parkes, Gastroenterology Unit, Addenbrooke’s Hospital, Cambridge CB2 2QQ, UK; miles.parkes{at}addenbrookes.nhs.uk
View Full Text

Citation

Parkes M On behalf of the IBD BioResource Investigators
IBD BioResource: an open-access platform of 25 000 patients to accelerate research in Crohn’s and Colitis

Publication history

  • Received May 4, 2019
  • Revised June 3, 2019
  • Accepted June 4, 2019
  • First published July 3, 2019.
Online issue publication 
August 07, 2019

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.